SPAC News
Stay updated with the latest SPAC news. Read about special purpose acquisition companies, new listings, market trends, and their impacts on industries and investors. Discover how SPACs shape the financial market and investment landscape.
May 1, 2025 at 6:08 PM
Cantor Equity Partners II, Inc. Announces Pricing of Upsized $240 Million Initial Public Offering
NEW YORK--(BUSINESS WIRE)--Cantor Equity Partners II, Inc. (Nasdaq: CEPT) (the “Company”) announced today the pricing of its upsized initial public offering of 24,000,000 Class A ordinary shares at $10.00 per share. The shares are expected to be listed on the Nasdaq Global Market under the symbol “CEPT” and begin trading on May 2, 2025. The offering is expected to close on May 5, 2025, subject to customary closing conditions. Cantor Fitzgerald & Co. is acting as the sole book-running manage...
May 1, 2025 at 5:51 PM
Gores Holdings X, Inc. Announces Pricing of Upsized $312 Million Initial Public Offering
BOULDER, Colo.--(BUSINESS WIRE)--Gores Holdings X, Inc. (the “Company”), a blank check company sponsored by an affiliate of The Gores Group and formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, today announced the pricing of its initial public offering of 31,200,000 units at a price of $10.00 per unit. The units will be listed on the Nasdaq Global Market and tra...
May 1, 2025 at 4:05 PM
Berto Acquisition Corp. Announces Closing of Upsized $300,150,000 Initial Public Offering
NEW YORK--(BUSINESS WIRE)--Berto Acquisition Corp. (Nasdaq: TACOU) (the “Company”), the ninth special purpose acquisition company sponsored by Harry You, today announced the closing of its upsized initial public offering of 30,015,000 units at $10.00 per unit, including 3,915,000 units sold pursuant to the full exercise of the underwriters’ over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $300,150,000. The units began trading on The Nasdaq Global...
Apr 29, 2025 at 6:56 PM
Berto Acquisition Corp. Announces Pricing of Upsized $261,000,000 Initial Public Offering
NEW YORK--(BUSINESS WIRE)--Berto Acquisition Corp. (NASDAQ: TACOU) (the “Company”), the ninth special purpose acquisition company sponsored by Harry You, today announced the pricing of its initial public offering of 26,100,000 units at $10.00 per unit. The units are expected to be listed on the Nasdaq Global Market (“Nasdaq”) and trade under the ticker symbol “TACOU” beginning April 30, 2025. Each unit consists of one ordinary share and one-half of one redeemable warrant. Once the securities co...
Apr 23, 2025 at 9:27 AM
Tether, SoftBank Group, and Jack Mallers Launch Twenty One, a Bitcoin-native Company, Through a Business Combination With Cantor Equity Partners
AUSTIN, Texas--(BUSINESS WIRE)--Twenty One Capital, Inc. (“Twenty One” or “the Company”), a newly formed entity, today announced it has entered into a definitive agreement for a business combination with Cantor Equity Partners, Inc. (“CEP”) (Nasdaq: CEP) (the “Business Combination”), a special-purpose acquisition company (SPAC) sponsored by an affiliate of Cantor Fitzgerald, a leading global financial services and real estate services holding company. At the closing of the Business Combination,...
Apr 16, 2025 at 9:03 AM
ICR, the Leading SPAC Communications and Advisory Firm, Publishes its Q1 2025 SPAC Market Update & Outlook
NEW YORK--(BUSINESS WIRE)--ICR, a leading strategic communications and advisory firm, today released its Q1 2025 SPAC Market Update & Outlook. In the first quarter of 2025, the SPAC IPO market saw the pricing of 19 IPOs, raising a total of $3.1 billion. Approximately 80% of the new SPAC IPOs this quarter were from serial SPAC issuers, raising $2.7 billion. Over the last three quarters the SPAC market has averaged 20 IPOs, raising $3.4 billion each quarter. This surge in the market is attrib...
Apr 16, 2025 at 8:45 AM
Ares Acquisition Corporation II Announces Monthly Contribution to Trust Account in Connection With Proposed Extension
NEW YORK--(BUSINESS WIRE)--Ares Acquisition Corporation II (NYSE: “AACT.U”, “AACT”, “AACT WS”) (“AACT” or the “Company”) announced today that the Company’s sponsor, Ares Acquisition Holdings II LP (the “Sponsor”), agreed to make monthly deposits directly to the Company’s trust account of $0.02 for each outstanding Class A ordinary share, par value $0.0001 per share (the “Class A Ordinary Shares”), of the Company, other than Class A Ordinary Shares held by the Sponsor upon any conversion of Clas...
Apr 14, 2025 at 12:05 PM
BM3EAC Corp. 2024 Annual Report
AMSTERDAM--(BUSINESS WIRE)--BM3EAC Corp. (the “Company”), a special purpose acquisition company incorporated under the laws of the Cayman Islands as an exempted company with limited liability and listed on Euronext Amsterdam, the regulated market operated by Euronext Amsterdam N.V., today published its annual report for the period 1 January 2024 to 31 December 2024. The annual report can be downloaded from the Company’s website via the following link: https://www.BrigadeM3EAC.com/documents IMPO...
Mar 24, 2025 at 8:01 AM
GrabAGun Nominates Donald Trump Jr. and Post-Closing Board of Directors and Advances Plans for Upcoming Public Listing
COPPELL, Texas & PALM BEACH, Fla.--(BUSINESS WIRE)--Metroplex Trading Company LLC, d.b.a. GrabAGun.com (the “Company” or “GrabAGun”), an online retailer of firearms, ammunition and related accessories, and Colombier Acquisition Corp. II (“Colombier II”) (NYSE: CLBR), a special purpose acquisition company led by Omeed Malik, a distinguished entrepreneur and investor with extensive experience in digital marketplace transactions, today announced the filing of a registration statement on Form S-4 (...
Feb 28, 2025 at 7:49 AM
BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3Kα-Targeting Medicines
SOUTH SAN FRANCISCO & BOSTON--(BUSINESS WIRE)--TheRas, Inc. d/b/a BridgeBio Oncology Therapeutics (“BBOT”), a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Kα malignancies, and Helix Acquisition Corp. II (Nasdaq: HLXB) (“Helix”), a special purpose acquisition company (SPAC) sponsored by affiliates of Cormorant Asset Management, today announced that they have entered into a definitive business combination a...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.